V
Virax Biolabs Group Ltd
NASDAQ:VRAX
Virax Biolabs Group Ltd
NASDAQ:VRAX
Price:
0.191
USD
-2.55%
Market Closed
Market Cap:
$1.4m
Relative Value
The Relative Value of one VRAX stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.191 USD, Virax Biolabs Group Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VRAX Relative Value
HIDDEN
Multiples Across Competitors
VRAX Competitors Multiples
Virax Biolabs Group Ltd Competitors
Virax Biolabs Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
V
|
Virax Biolabs Group Ltd
NASDAQ:VRAX
|
1.4m USD | 472.4 | -0.3 | 0.3 | 0.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
115.7B USD | 0.3 | 26.7 | 18.7 | 21 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
69.1B USD | 0.2 | 42.5 | 14.9 | 18.9 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.1B USD | 0.2 | 41.9 | 14.7 | 18.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.2B USD | 0.2 | 30.8 | 14.9 | 19.3 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.4B AUD | 2.6 | 33.4 | 24.8 | 24.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.9B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
61.4B CNY | 1.4 | 16.6 | 12.8 | 12.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 0.7 | 22 | 10.9 | 15.3 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66B HKD | 0.1 | 8.5 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
